Main Subject
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > List Building > List Building – Why I Put No Links on My Squeeze Pages Except for My Opt In Box

Tags

  • cycle
  • various
  • products
  • developing combination

  • Links

  • Online Electronic Day Trading -- 3 Basic Tips
  • Fixed or Variable Rate Mortgage?
  • Holland MI Real Estate: Strategies for Selling Your Home Or Buying One, Even With Bruised Credit
  • Main Subject - List Building – Why I Put No Links on My Squeeze Pages Except for My Opt In Box

    List Building – Why I Put No Links on My Squeeze Pages Except for My Op
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    t In Box

    List building is such a lucrative area online, and I get ques
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    tions all the time from my subscribers. They ask, should I put PPC on
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    y squeeze page, or should I have a link to my article directory on my s
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    queeze page, etc.

    Now here is the way I look at it. My squeeze pages
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    verage about 40% conversion to subscribers. My top squeeze page is at
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    65% conversion rate.

    Now, I have to tell you this: I have not tested
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    y theory. I am making too much money to mess with my formula. I am si
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    mply in the stages of widening my net so that I make more money by brin
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ing more leads into my system – you should be doing the same, once you
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    have learned to monetize your list, and you have quantified the monetiz
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ation.

    Here is my reasoning. If I put PPC on my pages, then some of t
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    e people who visit my squeeze page will click on the PPC instead of the
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    opt in box. Which is fine – but I make about $3 for each person that
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    licks into my opt in box. Would I really get $3 per click if I had PPC
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    on my site? (By the way, if your PPC average per click is $3, let me
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    tsofim.com/index.htm">articles page? Nope – I would rather get the
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    opt in, not the opt out to my articles page. Once they are on my email
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    list, then I can send them anywhere I want – including my articles page


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.mainsubjects.org.ua/article/71738/mainsubjects-List-Building--Why-I-Put-No-Links-on-My-Squeeze-Pages-Except-for-My-Opt-In-Box.html">List Building – Why I Put No Links on My Squeeze Pages Except for My Opt In Box</a>

    BB link (for phorums):
    [url=http://www.mainsubjects.org.ua/article/71738/mainsubjects-List-Building--Why-I-Put-No-Links-on-My-Squeeze-Pages-Except-for-My-Opt-In-Box.html]List Building – Why I Put No Links on My Squeeze Pages Except for My Opt In Box[/url]

    Related Articles:

    To Give Is To Receive - Gifts Keep Customers Coming Back

    Automating a Business to Run on Autopilot Part II

    7.5 Ways To Get More Sales Through Your Web Site

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com